All News

The University of Cambridge is considering whether to make more cash available to invest in campus spin-off companies. And whatever decision it makes will come in for criticism…

Shares in Oxford BioMedica, an Oxford University spin-out, fell 8.3 percent on news that the company was seeking up to £30 million to fund the Phase III trial of its a TroVax cancer immunotherapy product.

Jo Taylor, head of venture capital at 3i Group, argues that universities are too quick to hit the spin-out button.

Reports of incubators' demise were premature

Universities are funding more campus companies. Richard L. Hudson on the rules of a very risky game.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

Not all nanotechnology is hype. Carbon nanotubes are already inside a product near you.

The Cambridge-based company a.gain medical says it has invented the world's first urethral sensor for women – and is looking for further investment.

A team of European researchers is applying a technology used to measure airflow over aircraft wings to improve human heart implants.

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

UK-based AMDG's monitor for early detection of heart conditions particularly associated with diabetics is already selling in Germany. Now the company is now looking for support to enter into the US market.

Tracking 15 key technologies, fraud in nanotechnology - and other insights into R&D management

A spin-out from Sheffield that uses stem cells to help with conventional drug discovery is looking for investment to continue pre-clinical research on therapeutic applications and business development activities.

Nuala Moran takes a behind-the-scenes look at the strategies involved in Europe's biggest patent victory in years.

For her latest fortnightly funding column, Mary Lisbeth D'Amico set out to find European seed funders. That was as easy as finding a needle in a haystack.